Gynecologic Cancers

Gynecologic Cancers

Comparison of Neoadjuvant Chemotherapy Plus Surgery and Concomitant Chemoradiotherapy in Stage IB2 to IIB Cervical Carcinoma: Insights from EORTC-55994 Trial

1697538681_181023-TN23-Gyna.png

Gynecologic Cancers

Comparison of Neoadjuvant Chemotherapy Plus Surgery and Concomitant Chemoradiotherapy in Stage IB2 to IIB Cervical Carcinoma: Insights from EORTC-55994 Trial

Gynecologic Cancers

Phase III CHIPOR Trial: HIPEC Boosts Overall Survival and Peritoneal Progression-Free Survival in Women with First Platinum-Sensitive Relapse of Epithelial Ovarian Cancer

1695713631_250923-TN23-Gyne.png

Gynecologic Cancers

Comparing Surgical Approaches for Low-Risk Early-Stage Cervical Cancer: An International Study by Canadian Cancer Trials Group (SHAPE)

1693296163_310823-TN23-Gyne.png

Gynecologic Cancers Target therapy

GOG-0218 trial - KELIM scores

1679908611_240323-TN23-GYN.png

In a retrospective analysis of the GOG-0218 trial, a modelled CA-125 ELIMination rate constant K (#KELIM) could identify patients who...

Gynecologic Cancers

NORA trial - Niraparib favorable OS in patients with platinum sensitive recurrent ovarian cancer

1679830370_260123-TN23-Gyn.png

#Niraparib maintenance provides a favorable OS trend compared with placebo in patients with platinum sensitive recurrent ovarian cancer regardless of...

Gynecologic Cancers Target therapy

ENGOT/GCIG trial

1679826603_261222-TN22-GYN.png

In the prospective, randomized ENGOT/GCIG study by AGO s, GINECO, NSGO study groups, standard duration of #bevacizumab (15 months) treatment...

Lung Cancer Bladder Cancer Breast Cancer CNS Cancers Colorectal Cancer COVID-19 Gastroesophageal Cancer Gastrointestinal Cancer Genomics/Genetics Geriatric Oncology Gynecologic Cancers Head and Neck Cancers Health-Care Policy Hepatobiliary Cancer Immunotherapy Integrative Oncology Kidney Cancer Legislation Leukemia Lymphoma Multiple Myeloma Neuroendocrine Tumors Palliative Care Pancreatic Cancer Prostate Cancer Sarcoma Skin Cancer Survivorship Symptom management Thyroid Cancer

FDA approval of bevacizumab biosimilar

1676463478_FDA-2.png

On September 28th 2022, the FDA has approved Celltrion’s #bevacizumab biosimilar (bevacizumab-adcd) in six types of cancers which are: metastatic...

Gynecologic Cancers

SOLO1 trial

1676463229_ESMO-Gyne2-.png

The latest OS analysis of phase III SOLO1 trial was presented in #ESMO2022 supporting the use of maintenance #olaparib in...

Gynecologic Cancers

PAOLA – 1 trial

1676462887_ESMO-Gyne1-.png

The final Overall survival analysis data from the phase III PAOLA – 1 study presented by Ledermann showed that the...

Latest Articles

Adjuvant in RCC
View More